Stromal Myofibroblasts in Hepatic Carcinogenesis
Stromal Myofibroblasts in Hepatic Carcinogenesis
批准号:
7244481
负责人:
DAVID A. BRENNER
金额:
$15.47万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2011-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hepatic cirrhosis is the unifying risk factor for almost 90% of hepatocellular carcinomas (HCC). Chronic
inflammation and increased levelsextracellular matrix are two key features of hepatic cirrhosis. While it has
been shown that chronic activation of proinflammatory pathways in non-parenchymal cells plays a major role
in hepatocarcinogenesis, it is not known whether accumulation of activated myofibroblasts (MFs) and
subsequent changes in the hepatic microarchitecture contribute to carcinogenesis. Activated MFs are not
only found throughout the premalignant or malignant cirrhotic liver, but also accumulate around HCC lesion
suggesting that MFs and HCC interact closely. We have recently shown that activated hepatic stellate cells,
the main source of MFs in the liver, are a main target of Toll-like receptor (TLR) 4 in the injured liver. We
hypothesize that chronic exposure to TLR 4 ligands contributes to the profinflammatory environment of the
preneoplastic and that MFs, Kupffer form a cellular network that drives chronic inflammation, proliferation of
premalignant hepatocytes and angiogenesis and provides a niche that allow HCC to develop. We will define
the origin of HCC-associated MFs and compare gene expression patterns between HCC-associated MFs
and injury-associated MFs in mice and humans to determine whether they constitute the same cell
population (Aim 1). We will analyze how activation or depletion of hepatic stellate cells affects chemical- and
diet-induced hepatocarcinogenesis using a combination of in vivo luminescene, MRI and optical
deoxyhemoglobin imaging (Aim 2). To determine whether proinflammatory signaling in MFs contributes to
hepatocarcinogenesis, we will monitor NF-kappaB activation in hepatic MFs using a double transgenic reporter
mouse, and assess hepatocarcinogenesis in normal and bone-marrow chimeric TLR4-mutated mice and
mice with a MF-specific deletion of IkappaB kinase beta by MRI imaging (Aim 3). We will investigate whether
quiescent hepatic stellate cell, the major storage site of retinoids in the body, suppress hepatocarcinogenesis
in a retinoid-dependent manner by studying hepatocarcinogenesis in lecithin:retinol acyltransferase-deficient
mice which display a complete absence of retinoids in hepatic stellate cells (Aim 4). The pursuit of these four
aims will define the role of quiescent and activated hepatic fibroblast populations in hepatocarcinogenesis
and may point towards novel strategies for the prevention or treatment of HCC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of IL-17 signaling in alcohol-induced HCC
-
批准号:10627853
-
项目类别:
-
资助金额:$46.45万
-
财政年份:2021
-
负责人:DAVID A. BRENNER
-
依托单位:
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH
-
批准号:10680588
-
项目类别:
-
资助金额:$62.58万
-
财政年份:2014
-
负责人:DAVID A. BRENNER
-
依托单位:
Microbiome as Therapeutic Target in Alcoholic Hepatitis
-
批准号:8669778
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2013
-
负责人:DAVID A. BRENNER
-
依托单位:
Microbiome as Therapeutic Target in Alcoholic Hepatitis
-
批准号:8862332
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2013
-
负责人:DAVID A. BRENNER
-
依托单位:
Microbiome as Therapeutic Target in Alcoholic Hepatitis
-
批准号:8426498
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2013
-
负责人:DAVID A. BRENNER
-
依托单位:
Angiotensin II and NADPH Oxidase in Hepatic Fibrosis
-
批准号:7251525
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2005
-
负责人:DAVID A. BRENNER
-
依托单位:
Angiotensin II and NADPH Oxidase in Hepatic Fibrosis
-
批准号:6961767
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2005
-
负责人:DAVID A. BRENNER
-
依托单位:
RADIATION DOSIMETRY USING COMPUTATIONAL MOUSE MODELS
-
批准号:7181580
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2005
-
负责人:DAVID A. BRENNER
-
依托单位:
Angiotensin II and NADPH Oxidase in Hepatic Fibrosis
-
批准号:7491160
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2005
-
负责人:DAVID A. BRENNER
-
依托单位:
Angiotensin II and NADPH Oxidase in Hepatic Fibrosis
-
批准号:7482720
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2005
-
负责人:DAVID A. BRENNER
-
依托单位:
Angiotensin II and NADPH Oxidase in Hepatic Fibrosis
-
批准号:7119572
-
项目类别:
-
资助金额:$1.43万
-
财政年份:2005
-
负责人:DAVID A. BRENNER
-
依托单位:
Angiotensin II and NADPH Oxidase in Hepatic Fibrosis
-
批准号:7624318
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2005
-
负责人:DAVID A. BRENNER
-
依托单位:
Hepatic Stellate Cell Activation induced by HCV
-
批准号:6741363
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2003
-
负责人:DAVID A. BRENNER
-
依托单位:
Hepatic Stellate Cell Activation induced by Hepatitis C Virus
-
批准号:7281682
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2003
-
负责人:DAVID A. BRENNER
-
依托单位:
Hepatic Stellate Cell Activation induced by HCV
-
批准号:7126427
-
项目类别:
-
资助金额:$19.35万
-
财政年份:2003
-
负责人:DAVID A. BRENNER
-
依托单位:
Hepatic Stellate Cell Activation induced by HCV
-
批准号:6807025
-
项目类别:
-
资助金额:$38.52万
-
财政年份:2003
-
负责人:DAVID A. BRENNER
-
依托单位:
Hepatic Stellate Cell Activation induced by HCV
-
批准号:7468250
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2003
-
负责人:DAVID A. BRENNER
-
依托单位:
Hepatic Stellate Cell Activation induced by HCV
-
批准号:6940837
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2003
-
负责人:DAVID A. BRENNER
-
依托单位:
INDUCTION OF AP1 AND NFKB BY ETHANOL
-
批准号:6712916
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2002
-
负责人:DAVID A. BRENNER
-
依托单位:
Cond. Acceptance Post-Bac. Prog. Scholarship Fund
-
批准号:6802286
-
项目类别:
-
资助金额:$62.5万
-
财政年份:2002
-
负责人:DAVID A. BRENNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
牙周炎对腹主动脉瘤的作用和机制研究
-
批准号:82370953
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:朱亚琴
-
依托单位:
衰老引起的大脑内稳态失调和神经炎症的机理与干预研究
-
批准号:92049303
-
项目类别:重大研究计划
-
资助金额:400.0万元
-
批准年份:2020
-
负责人:袁钧瑛
-
依托单位:
GSDMD介导的牙周膜干细胞焦亡在牙周炎致病机制中的作用
-
批准号:32000513
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈秦
-
依托单位:
脱硫弧菌通过肠肝轴诱导肝纤维化的机制研究
-
批准号:31970746
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:耿燕
-
依托单位:
炎性肠病中富亮氨酸重复激酶2对树突细胞迁移的作用及其机制
-
批准号:31801172
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2018
-
负责人:严静
-
依托单位:
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
-
批准号:31760328
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2017
-
负责人:周建奖
-
依托单位:
HDAC6调控巨噬细胞和中性粒细胞向炎症部位浸润的分子机理研究
-
批准号:31701216
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:谢松波
-
依托单位:
TRPV2在原发性肝癌中癌变作用的研究
-
批准号:81171933
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:徐迅迪
-
依托单位:
骨化三醇降低IgA肾病患者尿蛋白的机制研究
-
批准号:81100503
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:刘立军
-
依托单位: